Bio Preventive Medicine Corp. (6810.TWO)

38.95 +0.95 (+2.50%) 收市：02:59PM CST

Bio Preventive Medicine Corp.

No.18, Taiyuan Street
6F.-1
Zhubei 302
Taiwan

https://www.bpmbiotech.com

版塊: Healthcare
行業: Biotechnology
全職員工: 

描述

Bio Preventive Medicine Corp, a clinical-staged biotech company, focusing on early detection and prevention of diseases. The company offers solutions in prevention, screening, and monitoring chronic diseases and cancers management. It provides DNlite test, a series of patented and clinically validated non-invasive urine test for diabetic kidney disease management, such as DNlite-IVD103 and DNlite-DN_Score. The company was founded in 2014 and is headquartered in Zhubei, Taiwan.

公司管治

截至 無 止，Bio Preventive Medicine Corp. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。